Stewart Washer says Zelda Therapeutics is catching up with market use, given the nature of cannabis regulation. Photo: Attila Csaszar

Zelda in cannabis autism trial

Clinical trials company Zelda Therapeutics aims to pave the way for the use of medicinal cannabis to treat a range of disorders.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 31/01/20

1 year TSR5 year TSR
304thZelira Therapeutics13%45%
632ndPeppermint Innovation-35%4%
733rdAusCann Group Holdings-54%51%
790thIntiger Group-67%-20%
677 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

$0 Issued
$903k Issued
$903k Issued
Total value as at the date of the transaction
Powered by Morningstar ®


146th↑Zelira Therapeutics$769k
148th↑Peppermint Innovation$710k
151st↑AusCann Group Holdings$671k
152nd↑Intiger Group$572k
200 listed industrial companies ranked by revenue.
Powered by Morningstar ®